Page last updated: 2024-10-18

imidazole and Candidiasis, Vulvovaginal

imidazole has been researched along with Candidiasis, Vulvovaginal in 2 studies

imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.

Candidiasis, Vulvovaginal: Infection of the VULVA and VAGINA with a fungus of the genus CANDIDA.

Research Excerpts

ExcerptRelevanceReference
" Those involving the patient include denial of illness, misconceptions regarding the nature of the infection or its treatment, a misunderstanding of symptomatic relief versus microbiologic cure, dislike of the dosage form, nonsupport of the sexual consort, or intolerance of side effects."1.28Vulvovaginitis: the role of patient compliance in treatment success. ( Nixon, SA, 1991)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Watson, MC1
Grimshaw, JM1
Bond, CM1
Mollison, J1
Ludbrook, A1
Nixon, SA1

Reviews

1 review available for imidazole and Candidiasis, Vulvovaginal

ArticleYear
Oral versus intra-vaginal imidazole and triazole anti-fungal agents for the treatment of uncomplicated vulvovaginal candidiasis (thrush): a systematic review.
    BJOG : an international journal of obstetrics and gynaecology, 2002, Volume: 109, Issue:1

    Topics: Acute Disease; Administration, Intravaginal; Administration, Oral; Antifungal Agents; Candidiasis, V

2002

Other Studies

1 other study available for imidazole and Candidiasis, Vulvovaginal

ArticleYear
Vulvovaginitis: the role of patient compliance in treatment success.
    American journal of obstetrics and gynecology, 1991, Volume: 165, Issue:4 Pt 2

    Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Imidazoles; Patient Compliance; Patien

1991